Yoltech Therapeutics

BiotechnologySeries CShanghai, Chinayoltx.com

Latest round

Series C

Last raised

May 2026

Total raised

$148M

Investors

15

About Yoltech Therapeutics

, trading as Yoltech Therapeutics, is a biotech company committed to developing gene-editing drugs against hereditary diseases and cardiovascular diseases. The company's founder, Dr. Yuxuan Wu, graduated from East China Normal University. The company focuses on the development of mRNA drugs and gene editing drugs by improving mRNA production platforms and lipid nanocarrier assembly processes through CRISPR, base editing and other gene editing tools.). The company's revenue is generated by developing mRNA drugs and gene editing drugs.

Who invested in Yoltech Therapeutics

15 investors across 5 rounds

See all investors in Yoltech Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    May 29, 2026

    Amount

    $74M

    Investors

    Locked

  2. Series B

    Sep 10, 2025

    Amount

    $45M

    Investors

    Locked

  3. Series A

    Nov 30, 2023

    Amount

    $14M

    Investors

    Locked

  4. Series A

    Aug 10, 2022

    Amount

    $15M

    Investors

    Locked

  5. Angel

    Feb 25, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Yoltech Therapeutics

Who invested in Yoltech Therapeutics?

Yoltech Therapeutics has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Yoltech Therapeutics raised?

Yoltech Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Yoltech Therapeutics last raise money?

Yoltech Therapeutics's most recent round on record is a Series C, in May 2026.

What does Yoltech Therapeutics do?

, trading as Yoltech Therapeutics, is a biotech company committed to developing gene-editing drugs against hereditary diseases and cardiovascular diseases.

Where is Yoltech Therapeutics headquartered?

Yoltech Therapeutics is headquartered in Shanghai, China.

Which VCs invest in companies like Yoltech Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Yoltech Therapeutics's stage. Their profiles are linked below.

Raising like Yoltech Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.